One Stop Shop for All Your Market Research Reports

Global Transdermal Skin Patches Market 2019 Industry Research Report

The global Transdermal Skin Patches market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Skin Patches market based on company, product type, end user and key regions. This report studies the global market size of Transdermal Skin Patches in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Skin Patches in these regions. This research report categorizes the global Transdermal Skin Patches market by top players/brands, region, type and end user. This report also studies the global Transdermal Skin Patches market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Johnson & Johnson Novartis AG Mylan N.V. Teva Pharmaceutical Industries Luye Pharma Group Hisamitsu Pharmaceutical Mundipharma International Purdue Pharma Market size by Product Drug in Adhesive Matrix Reservoir Vapor Other Market size by End User Hospital Pharmacies Retail Pharmacies Online Pharmacies Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Transdermal Skin Patches market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Transdermal Skin Patches market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Transdermal Skin Patches companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Transdermal Skin Patches submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Transdermal Skin Patches are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Skin Patches market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Transdermal Skin Patches Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Transdermal Skin Patches Market Size Growth Rate by Product 1.4.2 Drug in Adhesive 1.4.3 Matrix 1.4.4 Reservoir 1.4.5 Vapor 1.4.6 Other 1.5 Market by End User
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 324563
  • Pharmaceuticals and Healthcare
Published on 03-Jan
Number of Pages 112
Publisher Name QY Research
Editor Rating